With recognized core competencies in solution design, material know-how and product industrialization, we are a strategic engineering partner for innovative systems in Healthcare, Transportation & Electronics, General Industry and Food & Beverage. Read more about us.
With its clear focus on high‑value components and strengthening its core competencies, Datwyler is strategically well positioned to benefit from long‑term growth trends.
Datwyler gained momentum in the first half of 2025 despite a challenging environment.
Datwyler is streamlining its U.S. production network and transferring the production and distribution activities of the Vandalia site in Ohio to two existing Datwyler U.S. sites.
Datwyler strengthens its market position and drives growth by commencing serial supply of premium components for GLP-1 therapies, reflecting its strategic investments and early-stage development partnerships within the rapidly expanding injectable drug market.
The 67th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 18 March 2025.
Embracing change with an open mind-set
I am proud to work for a company that encourage its employees to adopt an open mind-set that allows them to embrace change. As a consequence, the organization will be able to alter its direction swiftly when required or adjust to operate successfully.
Oda Suffeleers
Head of Global Compensation & Benefits
Significant increase of energy efficiency. Use of natural gas to generate electricity, heat and cooling for the whole production plant. Reduction of CO2 emission by 900 tons per year. Investment of CHF 1.7 million.
Combined heat and power unit at Datwyler plant in Pregnana, Italy
Plan for solar panels at the Indian plant (2021)
Use of solar panels to generate electricity will help reduce intake from the public power grid. Supply of more than 2’100 MWh of electricity per year. Reduction of CO2 emission by some 1’800 tons per year. Second phase with solar panels on roof of new building (2022) will add another 2’500 MWh of electricitiy and reduce CO2-emissions by another 2’200 tons.
Plan for solar panels at Datwyler plant in Kesurdi, India
We are dedicated to continuous improvement in all we do. Our quality management system is supported by digitalisation thus enabling analysis, exchange of knowledge, and standardisation. We use a risk-based approach and our expertise to meet the changing needs of our customers and other stakeholders and to shape future oriented processes.
I am proud to work for a company that contributes so much to world health. At our core values, we continue to bring new innovation and offer the highest quality products to support our Pharma partners.
Douglas Stout
Head of Sales, North America
